TF and neoplasm: Classical biomarkers such as D-dimer, fibrinogen, and coagulation factors levels, as well as thrombocyte count, can be complemented by more precise biomarkers such as TF-bearing microparticles, soluble P-selectin levels, and even the presence of tumor molecular aberrations.